Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
J Thromb Haemost ; 2(1): 128-34, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14717976

ABSTRACT

Activation of the contact system in patients treated with fibrinolytic agents may be an important source of thrombin that activates thrombin-activated fibrinolysis inhibitor (TAFI) and attenuates fibrinolysis. Factor (F)XIIa in plasma increased 2-fold over 60 min in patients given either tissue plasminogen activator (t-PA) or streptokinase (SK). To determine whether FXIIa-mediated generation of thrombin and activated TAFI (TAFIa) attenuates fibrinolysis in vitro, plasma clots were incubated with SK (250 U mL-1) or t-PA (2.5 g mL-1) and the rate of lysis was measured. Plasma FXIIa impaired lysis judging from marked acceleration when 2.5 micro m corn trypsin inhibitor were added (lysis increased by 172 +/- 144% for SK and 40 +/- 31% for t-PA vs. no inhibitor, n = 16, P < 0.01). Moreover, inhibition of thrombin with hirudin and TAFIa with carboxypeptidase inhibitor accelerated lysis. We conclude that activation of FXII increases thrombin generation, which promotes TAFIa-mediated attenuation of fibrinolysis.


Subject(s)
Carboxypeptidases/metabolism , Factor XII/metabolism , Fibrinolytic Agents/pharmacology , Thrombin/metabolism , Carboxypeptidase B2/metabolism , Factor XIIa/metabolism , Factor Xa Inhibitors , Fibrinolysis/drug effects , Humans , In Vitro Techniques , Streptokinase/pharmacology , Thrombin/antagonists & inhibitors , Tissue Plasminogen Activator/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL